Use of sodium bicarbonate as a means of ameliorating doxorubicin-induced dermal necrosis in rats.
D000818:Animals; D001639:Bicarbonates / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects*; D007271:Injections, Intradermal; D009336:Necrosis / Q000139:chemically induced / Q000517:prevention & control; D051381:Rats; D012871:Skin Diseases / Q000139:chemically induced / Q000517:prevention & control*; D017693:Sodium Bicarbonate; D013997:Time Factors
D001639:Bicarbonates; D004317:Doxorubicin; D017693:Sodium Bicarbonate